Our History
Founded in 2017 by CEO and inventor Michael Gertner, MD; and based in Issaquah, Washington, Olympic Ophthalmics is a medical device company focused on developing novel therapies to treat ophthalmic and other disease categories with high unmet needs. Our leadership team brings extensive experience in neuromodulation, energy-based technology, and medical device technology.
Our first product, iTEAR®100, cleared by the FDA in 2020, is a novel neurostimulation device that increases tear production through gentle stimulation of the external nasal nerve. It is drug-free and drop-free – and has been proven in robust clinical trials.
![skiing-itear-100 skiing-itear-100](https://olympicophthalmics.com/wp-content/uploads/elementor/thumbs/skiing-itear-100-pfhymjfni7g3zal4shnqt486888o5rkt5tvhklzt36.png)